Fig. 3From: Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1Correlation between risk score and tumor immunogenicity in the TCGA-LUAD cohort. ESTIMATE algorithm indicates that immune (A) and ESTIMATE (B) scores in the high-risk group are significantly lower than those in the low-risk group. Immune (C) and ESTIMATE (D) scores are negatively associated with the risk score. E Comparison of the composition of 28 immune cell subsets in LUAD between the high- and low-risk groups. F–I In the low-risk group, there were decreased expression levels of mismatch repair genes, MSH2 and MSH6Back to article page